期刊
NEUROLOGY
卷 89, 期 10, 页码 1028-1034出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0000000000004336
关键词
-
资金
- Alzheimer's Disease Neuroimaging Initiative (ADNI) (NIH) [U01 AG024904]
- DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
- National Institute on Aging
- National Institute of Biomedical Imaging and Bioengineering
- AbbVie
- Alzheimer's Association
- Alzheimer's Drug Discovery Foundation
- Araclon Biotech
- Bio-Clinica, Inc.
- Biogen
- Bristol-Myers Squibb Company
- CereSpir, Inc.
- Cogstate
- Eisai Inc.
- Elan Pharmaceuticals, Inc.
- Eli Lilly and Company
- EuroImmun
- F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.
- Fujirebio
- GE Healthcare
- IXICO Ltd.
- Janssen Alzheimer Immunotherapy Research & Development, LLC
- Johnson & Johnson Pharmaceutical Research & Development LLC
- Lumosity
- Lundbeck
- Merck Co., Inc.
- Meso Scale Diagnostics, LLC
- NeuroRx Research
- Neurotrack Technologies
- Novartis Pharmaceuticals Corporation
- Pfizer Inc.
- Piramal Imaging
- Servier
- Takeda Pharmaceutical Company
- Transition Therapeutics
- Canadian Institutes of Health Research
- National Health & Medical Research Council-Australian Research Council (NHMRC-ARC) Dementia Research Development Fellowship [APP1111603]
- NIH [K01 AG051718]
Objective: To clarify associations between APOE epsilon 4 allele and age on longitudinal rates of b-amyloid (Ab) accumulation within A beta+ and A beta-older individuals without dementia. Methods: We analyzed 595 older adults without dementia classified cross-sectionally as A beta- (n 5 325) and A beta+ (n 5 270) using longitudinal florbetapir PET. The influence of age and APOE genotype on longitudinal accumulation of Ab was examined with linear mixed models. Results: APOE epsilon 4 and older age were associated with higher risk of being classified as A beta+ at baseline. The annual rate of Ab accumulation was significantly greater than zero for A beta-epsilon 3 (0.0021 6 0.0007 standardized uptake value ratio [ SUVR] units) and A beta-epsilon 4 (0.0044 6 0.0010 SUVR units), as well as A beta+ epsilon 3 (0.0141 6 0.0019 SUVR units) and A beta+ epsilon 4 (0.0126 6 0.0018 SUVR units). Ab accumulation was significantly faster in A beta-epsilon 4 compared to A beta-epsilon 3 and A beta-epsilon 2. Rates of Ab accumulation did not differ significantly between A beta+ APOE groups. Older age was associated with higher rates of Ab accumulation in the A beta-group. Conclusions: APOE epsilon 4 carriage and older age were predictors of longitudinal Ab accumulation within the A beta-group but not the A beta+ group. APOE epsilon 2 carriage was protective against longitudinal Ab accumulation within the A beta-group. APOE genotype in conjunction with chronologic age may aid in participant selection for primary prevention trials aimed at halting Ab accumulation before abnormal levels are reached.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据